The U.S. Federal Trade Commission is probing complaints about telehealth platform Hims & Hers regarding its advertising and ...

Hims & Hers has been an incredible stock to own over the last few years, making shareholders rich. It has $2 billion in ...

Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...

At $13.6 billion in market capitalization, Hims & Hers stock costs a pricey 70 times trailing earnings. It's even more ...

Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...

We recently published 10 Stocks That Vanished in Value Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing ...

Het nieuwe koersdoel van $48 van TD Cowen is gebaseerd op ongeveer 4x FY2 EV/Sales, hoewel het bedrijf zijn Hold-advies handhaafde vanwege de geïdentificeerde korte termijn dynamiek en verhoogde ...

Dudum is still the largest individual holder of Hims & Hers’ stock, with the latest Form 4 showing that he owned 8 million ...

Hims & Hers Health ( NYSE: HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s ...

Investing.com - Hims Hers Health (NYSE: HIMS) rapporteerde op maandag voor het tweede kwartaal een winst die hoger is dan verwacht en een omzet die achterblijft bij de voorspellingen.

Ten large-cap stocks, including CRWV, COHR & AMZN, were the worst performers last week. Weak results, downgrades, and FTC ...